Faith Pearson Crosby
Nurse Practitioner · Gulfport, MSNPI 1043977507
Payments from drug & device makers
Across 93 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$417
- Boehringer Ingelheim$223
- Lexicon Pharmaceuticals, Inc.$202
- Bayer$97
- Actelion Pharmaceuticals US, Inc.$97
- AbbVie$92
- plus $613 from 13 others
What the payments were for
- Food & beverage$1,742100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 24 | $417 |
| Boehringer Ingelheim | 14 | $223 |
| Lexicon Pharmaceuticals, Inc. | 4 | $202 |
| Bayer | 4 | $97 |
| Actelion Pharmaceuticals US, Inc. | 5 | $97 |
| AbbVie | 6 | $92 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $88 |
| Amgen | 5 | $77 |
| Merck | 3 | $73 |
| Novo Nordisk | 4 | $70 |
| Pfizer | 5 | $69 |
| Scpharmaceuticals Inc. | 3 | $55 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| Philips North America LLC | 2 | $41 |
| Heartflow, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Abiomed | 1 | $18 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inpefa$113
How this compares
$1,742 in reported general payments places this provider in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 193 | $167,576 |
| EntrestoSacubitril/Valsartan | 68 | $89,996 |
| XareltoRivaroxaban | 54 | $60,865 |
| Repatha SureclickEvolocumab | 31 | $30,821 |
| JardianceEmpagliflozin | 11 | $18,443 |
| JanuviaSitagliptin Phosphate | 14 | $12,282 |
| FarxigaDapagliflozin Propanediol | 11 | $9,496 |
| Clonidine | 42 | $3,841 |
| Ranolazine ErRanolazine | 45 | $2,593 |
| Memantine Hcl | 23 | $2,436 |
| Valsartan | 82 | $2,376 |
| Rosuvastatin Calcium | 223 | $2,169 |
| Metoprolol Succinate | 196 | $2,146 |
| Midodrine Hcl | 21 | $1,769 |
| Atorvastatin Calcium | 163 | $1,712 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $69 | $167,576193 claims |
| NovartisEntresto | $417 | $89,99668 claims |
| Johnson & JohnsonXarelto | $20 | $60,86554 claims |
| Boehringer IngelheimJardiance | $223 | $18,44311 claims |
| MerckJanuvia | $73 | $12,28214 claims |
| AstraZenecaFarxiga | $14 | $9,49611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Gulfport
- Mariah CoxGulfport$14K
- Brittany HicksGulfport$14K
- Robin AllenGulfport$6K
- Michelle StewartGulfport$6K
- Jared DeloachGulfport$6K
- Brenda WakhamGulfport$5K
- Olivia GennarelliGulfport$5K
- Christina TreppendahlRidgeland$673K
- Catherine WellsJackson$75K
- Jo Anna WarrenJackson$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.